OLIVOLA, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 2.261
EU - Europa 169
AS - Asia 88
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 2.523
Nazione #
US - Stati Uniti d'America 2.258
SG - Singapore 50
IE - Irlanda 38
IT - Italia 25
SE - Svezia 25
DE - Germania 22
RU - Federazione Russa 22
CN - Cina 19
UA - Ucraina 11
GB - Regno Unito 10
IN - India 10
FR - Francia 8
KR - Corea 5
CA - Canada 3
FI - Finlandia 3
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
HK - Hong Kong 1
JP - Giappone 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.523
Città #
Wilmington 794
Houston 628
Woodbridge 316
Fairfield 80
Chandler 72
Ashburn 59
Singapore 46
Seattle 37
Dublin 34
Cambridge 28
Ann Arbor 27
Medford 25
Santa Clara 17
Lawrence 12
New York 11
Rome 11
Dearborn 10
Beijing 9
Pune 8
San Diego 8
Menlo Park 6
Jacksonville 5
London 4
Milan 4
Munich 4
Norwalk 4
Philadelphia 4
Creede 3
Palo Alto 3
Redwood City 3
Seoul 3
Boardman 2
Brescia 2
Brno 2
Falls Church 2
Moscow 2
Nanjing 2
Nuremberg 2
Shenzhen 2
Toronto 2
Turin 2
Washington 2
Changsha 1
Council Bluffs 1
Esslingen am Neckar 1
Etobicoke 1
Hefei 1
Helsinki 1
Kilburn 1
Kunming 1
Lausanne 1
Miami 1
Nagold 1
Phoenix 1
Prescot 1
Saint Petersburg 1
San Francisco 1
Shanghai 1
Southwark 1
Tokyo 1
Verona 1
Villa Castelli 1
Wuhan 1
Xi'an 1
Totale 2.319
Nome #
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 433
Catecholamine-based treatment in AD patients: expectations and delusions 366
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 322
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 315
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 263
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 259
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 249
Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies (Neurological Sciences, (2019), 40, 9, (1917-1923), 10.1007/s10072-019-03920-5) 127
Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies 96
Validation of the Italian version of the PSP Quality of Life questionnaire 46
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 40
An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease 36
Effects of prismatic lenses on lateral axial dystonia in Parkinson's disease: a pilot study 30
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 9
Totale 2.591
Categoria #
all - tutte 6.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020569 0 0 0 0 61 71 70 71 88 85 60 63
2020/2021563 68 69 70 63 62 63 68 49 12 12 25 2
2021/2022137 1 5 5 11 2 18 4 5 10 15 22 39
2022/2023173 13 22 8 16 19 35 19 14 17 0 4 6
2023/202479 13 3 7 1 13 30 1 1 1 2 0 7
2024/2025127 4 50 31 22 20 0 0 0 0 0 0 0
Totale 2.591